PT3459542T - Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal - Google Patents

Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal

Info

Publication number
PT3459542T
PT3459542T PT177996741T PT17799674T PT3459542T PT 3459542 T PT3459542 T PT 3459542T PT 177996741 T PT177996741 T PT 177996741T PT 17799674 T PT17799674 T PT 17799674T PT 3459542 T PT3459542 T PT 3459542T
Authority
PT
Portugal
Prior art keywords
preventing
trigeminal neuralgia
carbamate compound
treating trigeminal
treating
Prior art date
Application number
PT177996741T
Other languages
English (en)
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of PT3459542T publication Critical patent/PT3459542T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT177996741T 2016-05-19 2017-05-18 Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal PT3459542T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160061386 2016-05-19

Publications (1)

Publication Number Publication Date
PT3459542T true PT3459542T (pt) 2021-08-24

Family

ID=60325324

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177996741T PT3459542T (pt) 2016-05-19 2017-05-18 Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal

Country Status (15)

Country Link
US (2) US11207295B2 (pt)
EP (1) EP3459542B1 (pt)
JP (1) JP6960415B2 (pt)
KR (1) KR102421013B1 (pt)
CN (1) CN109310669B (pt)
AU (1) AU2017267160B2 (pt)
BR (1) BR112018073556A2 (pt)
CA (1) CA3024284C (pt)
DK (1) DK3459542T3 (pt)
ES (1) ES2887338T3 (pt)
MX (1) MX2018014081A (pt)
PL (1) PL3459542T3 (pt)
PT (1) PT3459542T (pt)
RU (1) RU2751504C2 (pt)
WO (1) WO2017200317A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11147798B2 (en) 2016-12-14 2021-10-19 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease
JP7408643B2 (ja) * 2018-09-21 2024-01-05 エスケー バイオファーマスティカルズ カンパニー リミテッド カルバメート化合物及びそれを含む製剤の急性ストレス障害又は心的外傷後ストレス障害の予防、軽減又は治療のための使用
JP7369185B2 (ja) * 2018-10-19 2023-10-25 エスケー バイオファーマスティカルズ カンパニー リミテッド カルバメート化合物の糖尿病性末梢神経障害又は化学療法剤誘発性末梢神経障害の予防、緩和又は治療のための使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) * 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
JP4276838B2 (ja) * 2001-02-27 2009-06-10 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 疼痛(pain)の治療における使用のためのカルバメート化合物
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
JP4227121B2 (ja) * 2005-06-08 2009-02-18 独立行政法人科学技術振興機構 神経因性疼痛治療剤
CN102803233B (zh) * 2009-06-22 2017-03-01 爱思开生物制药株式会社 制备氨基甲酸(r)‑1‑芳基‑2‑四唑基‑乙酯的方法
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
EA201300558A1 (ru) * 2010-11-11 2013-11-29 Акрон Моликьюлис Гмбх Соединения и способы для купирования боли
RS56590B1 (sr) * 2014-05-09 2018-02-28 Tecnimede Sociedade Tecnico Medicinal S A (r)-pirlindol i njegove farmaceutski prihvatljive soli za upotrebu u medicini

Also Published As

Publication number Publication date
EP3459542A1 (en) 2019-03-27
DK3459542T3 (da) 2021-09-13
AU2017267160A1 (en) 2018-12-13
EP3459542A4 (en) 2020-01-08
PL3459542T3 (pl) 2021-12-27
BR112018073556A2 (pt) 2019-03-19
MX2018014081A (es) 2019-09-02
US20220087976A1 (en) 2022-03-24
RU2751504C2 (ru) 2021-07-14
KR102421013B1 (ko) 2022-07-14
JP6960415B2 (ja) 2021-11-05
US11207295B2 (en) 2021-12-28
US20190175555A1 (en) 2019-06-13
WO2017200317A1 (ko) 2017-11-23
ES2887338T3 (es) 2021-12-22
AU2017267160B2 (en) 2022-11-10
CA3024284A1 (en) 2017-11-23
JP2019516722A (ja) 2019-06-20
CA3024284C (en) 2024-01-23
CN109310669A (zh) 2019-02-05
RU2018144784A3 (pt) 2020-08-11
RU2018144784A (ru) 2020-06-19
EP3459542B1 (en) 2021-06-30
KR20170131241A (ko) 2017-11-29
CN109310669B (zh) 2022-02-22

Similar Documents

Publication Publication Date Title
HRP20181772T1 (hr) Spoj za obradu gnojiva koje sadrži ureu
GB2555517B (en) Mitigation of return-oriented programming attacks
IL283267B (en) Inhibitors of menin–mll interaction
PL3512850T3 (pl) Inhibitory interakcji menina-mll
HK1252996A1 (zh) 用於治療癲癇的方法
PT3348557T (pt) Imidazo[1,2a]piridinas para o tratamento ou prevenção de hiperuricemia ou gota
HK1252692A1 (zh) 治療或者預防蛋白質構象病的方法
ZA201704116B (en) 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2h-pyrrol-5-amine compound inhibitors of beta-secretase
SG11201708793SA (en) Crystals of azabicyclic compound
IL267199A (en) A method for treating epilepsy
PL3459543T3 (pl) Związek karbaminianowy do zapobiegania lub leczenia fibromialgii
IL272092A (en) Methods for treating changes in behavior
KR101675359B9 (ko) 네오아가로올리고당을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 조성물
PT3459542T (pt) Utilização de composto carbamato para prevenção ou tratamento de neuralgia trigeminal
IL274979A (en) Methods for the prevention and treatment of neurogenic seizures
RS61238B1 (sr) Kristal jedinjenja sa inhibitornom aktivnošću prema jak
ZA202103106B (en) Heterocyclic compounds for the treatment of epilepsy
IL262916A (en) Treatment of side effects resulting from chemo-nervous disorder
IL261133A (en) Titration of severnopedol
GB201701928D0 (en) Compounds for the treatment of hyperglycaemia